Has Michael Novak, MD received payments from drug or device companies?

Yes. Drug and device makers reported $70,636 in general payments to Michael Novak, MD across 233 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Novak, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Novak, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Novak, MD

Retina Specialist · Beachwood, OHNPI 1265437867

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (47.1%), ownership interests and food and beverage — rather than concentrated in one kind of arrangement. US Retina LLC accounts for 88.2% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $43,720 and has fallen 97.3% since, to $1,165 in 2025.

$70,636in general payments, 2019–2025

Across 233 payments — averaging $303.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

US Retina LLC$62K
Regeneron Healthcare Solutions, Inc.$2K
Genentech USA, Inc.$1K
AbbVie$1K
Dutch Ophthalmic, USA$962
Alimera Sciences, Inc.$952
plus $2K from 14 others

What the payments were for

Travel & lodging$590%
Food & beverage$8,31712%
Ownership interest$28,97541%
Other$33,28547%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
US Retina LLC	8	$62,310
Regeneron Healthcare Solutions, Inc.	72	$2,277
Genentech USA, Inc.	31	$1,069
AbbVie(2 entities)	26	$1,001
Dutch Ophthalmic, USA	8	$962
Alimera Sciences, Inc.	25	$952
Apellis Pharmaceuticals, Inc.	16	$670
Astellas Pharma US Inc	12	$429
Novartis	14	$291
Coherus Oncology, Inc.	2	$209
Bausch & Lomb Americas Inc.	3	$135
Alcon	4	$82
Intuitive Surgical	3	$59
ANI Pharmaceuticals, Inc.	2	$41
Biogen	2	$37
Carl Zeiss Meditec USA, Inc.	1	$30
Harrow Eye, LLC	1	$28
Baxter Healthcare	1	$27
NEW World Medical,inc.	1	$15
Rayner Intraocular Lenses Limited	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$70,636 in reported general payments places this provider in the 85th percentile of 69 retina specialist providers in Ohio.

See all retina specialist providers in Ohio →

Medicare billing

Part B allowed, 2024

$4,188,763

Medicare patients

1,113

Services billed

34,343

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	266	$6,969
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol	22	$1,423
Ofloxacin	108	$1,111
Latanoprost	93	$646
Acetazolamide	70	$616
Ketorolac Tromethamine	53	$573
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	22	$478
Eplerenone	14	$471
ErythromycinErythromycin Base	14	$151
Timolol Maleate	25	$125
Dorzolamide Hcl	11	$70
Brimonidine Tartrate	31	$63

Paid to pharmacies, not to this prescriber.

Other retina specialist in Beachwood

Joseph ConeyBeachwood$980K
David MillerBeachwood$299K
Scott PendergastBeachwood$66K
Llewelyn RaoBeachwood$58K
Jerome SchartmanBeachwood$30K
Sean PlattBeachwood$23K
Lediana GoduniBeachwood$9K
Shawn LewisBeachwood$7K
David ShiehBeachwood$3K
Hernando ZegarraBeachwood$478

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →